Costs for screening, intervention and hospital treatment generated by the Malmö Preventive Project: A large-scale community screening programme

Journal of Internal Medicine

Volumn 251, Issue 1, 2002, Pages 44-52

  Norinder, A ^a   Persson, U ^a   Nilsson, P ^b   Nilsson, J A ^b   Hedblad, B ^b   Berglund, G ^b  

^a SWEDISH INSTITUTE FOR HEALTH ECONOMICS   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cardiovascular; Cost analysis; Prevention; Screening programme

Indexed keywords

ADOLESCENT; ADULT; ALCOHOL ABUSE; ALCOHOLISM; ARTICLE; BREAST CANCER; CARDIOVASCULAR DISEASE; CHILD; COHORT ANALYSIS; COMMUNITY CARE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEALTH CARE COST; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RATING SCALE; REDUCTION; RETROSPECTIVE STUDY; SCREENING; SWEDEN; TYPES OF STUDY;

ADULT; ALCOHOL-RELATED DISORDERS; ALCOHOLISM; BREAST NEOPLASMS; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; FEMALE; HEALTH CARE COSTS; HOSPITAL COSTS; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; MALE; MASS SCREENING; MIDDLE AGED; PREVENTIVE HEALTH SERVICES; RETROSPECTIVE STUDIES; RISK FACTORS; SWEDEN;

EID: 0036197816     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.2002.00923.x     Document Type: Article

References (30)

1. Blood pressure, stroke, and coronary heart disease, part 2. Short term reductions in blood pressure: Overview of randomised drug trials in their epidemiological context
2. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
3. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
4. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: (UKPDS 38)
5. Cost-effectiveness of the North Karelia hypertension programme 1972-1977
6. Pressure to treat and pressure to cost: A review of the cost-effectiveness analysis
7. Cost effectiveness of incremental programmes for lowering serum cholesterol concentration: Is individual intervention worth while?
8. Cost effectiveness of lowering cholesterol concentration with statins in patients with and without pre-existing coronary heart disease: Life table method applied to health authority population
9. Cost-effectiveness of cholesterol lowering. Results from the Scandinavian simvastatin survival study (4S)
10. The cost effectiveness of lipid lowering in Swedish primary health care
11. The West of Scotland coronary prevention study: Economic benefit analysis of primary prevention with pravastatin
12. Clinical guidelines - The hidden costs
13. Alcohol advice in primary health care - Is it a wise use of resources?
14. The health economics of the treatment of hyperlipidaemia and hypertension
15. The cost-effectiveness of lipid lowering in patients with diabetes: Results from the 4S trial
16. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
17. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
18. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
19. Community-based preventive medical department for individual risk factor assessment and intervention in an urban area
20. Cardiovascular risk groups and mortality in an urban Swedish male population: The Malmö Preventive Project
21. Long-term outcome of the Malmö Preventive Project: Mortality and cardiovascular morbidity
22. The cost-effectiveness of a new antihypertensive drug, doxazosin
23. Lipid-lowering therapy: Cost estimates in Sweden. The social and economic contexts of coronary prevention